Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 3661 AL 3675

TRIM family proteins: roles in proteostasis and neurodegenerative diseases

Zhu Y, Afolabi LO, Wan X, Shim JS, Chen L.

Open Biol. 2022 Aug;12(8):220098. doi: 10.1098/rsob.220098. Epub 2022 Aug 10.

Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases

Zhang Y, Wang Y, Zhao Z, Peng W, Wang P, Xu X, Zhao C.

Eur J Pharmacol. 2022 Sep 15;931:175178. doi: 10.1016/j.ejphar.2022.175178. Epub 2022 Aug 7.

Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases

Sahebnasagh A, Eghbali S, Saghafi F, Sureda A, Avan R.

Immun Ageing. 2022 Aug 11;19(1):36. doi: 10.1186/s12979-022-00292-x.

Emerging Role of NLRP3 Inflammasome/Pyroptosis in Huntington's Disease

Paldino E, Fusco FR.

Int J Mol Sci. 2022 Jul 28;23(15):8363. doi: 10.3390/ijms23158363.

Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders

De Plano LM, Calabrese G, Conoci S, Guglielmino SPP, Oddo S, Caccamo A.

Int J Mol Sci. 2022 Aug 5;23(15):8714. doi: 10.3390/ijms23158714.

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

Behl T, Makkar R, Sehgal A, Sharma N, Singh S, Albratty M, Najmi A, Meraya AM, Bungau SG.

Molecules. 2022 Aug 4;27(15):4970. doi: 10.3390/molecules27154970.

Time-Restricted Ketogenic Diet in Huntington's Disease: A Case Study

Phillips MCL, McManus EJ, Brinkhuis M, Romero-Ferrando B.

Front Behav Neurosci. 2022 Jul 29;16:931636. doi: 10.3389/fnbeh.2022.931636. eCollection 2022.

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

Bilbao A, Spanagel R.

BMC Med. 2022 Aug 19;20(1):259. doi: 10.1186/s12916-022-02459-1.

Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases

Islam F, Islam MM, Khan Meem AF, Nafady MH, Islam MR, Akter A, Mitra S, Alhumaydhi FA, Emran TB, Khusro A, Simal-Gandara J, Eftekhari A, Karimi F, Baghayeri M.

Chemosphere. 2022 Nov;307(Pt 3):136020. doi: 10.1016/j.chemosphere.2022.136020. Epub 2022 Aug 16.

Emotion expression through spoken language in Huntington disease

Gallezot C, Riad R, Titeux H, Lemoine L, Montillot J, Sliwinski A, Bagnou JH, Cao XN, Youssov K, Dupoux E, Bachoud Levi AC.

Cortex. 2022 Oct;155:150-161. doi: 10.1016/j.cortex.2022.05.024. Epub 2022 Jul 19.

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders

Shen Y, Qian L, Luo H, Li X, Ruan Y, Fan R, Si Z, Chen Y, Li L, Liu Y.

Brain Sci. 2022 Aug 10;12(8):1057. doi: 10.3390/brainsci12081057.

Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy

Jurcau A, Jurcau MC.

Biomedicines. 2022 Aug 5;10(8):1895. doi: 10.3390/biomedicines10081895.

Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease

White A, McGlone A, Gomez-Pastor R.

Biomedicines. 2022 Aug 15;10(8):1979. doi: 10.3390/biomedicines10081979.

The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function

Gray NE, Farina M, Tucci P, Saso L.

Biomedicines. 2022 Aug 21;10(8):2043. doi: 10.3390/biomedicines10082043.

New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases

Sun Y, Yang Y, Liu S, Yang S, Chen C, Lin M, Zeng Q, Long J, Yao J, Yi F, Meng L, Ai Q, Chen N.

Cells. 2022 Aug 16;11(16):2529. doi: 10.3390/cells11162529.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias